Silence Therapeutics (SLN) Shares Outstanding: 2019-2025
Historic Shares Outstanding for Silence Therapeutics (SLN) over the last 5 years, with Sep 2025 value amounting to $141.7 million.
- Silence Therapeutics' Shares Outstanding fell 23.00% to $141.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $141.7 million, marking a year-over-year decrease of 23.00%. This contributed to the annual value of $141.7 million for FY2024, which is 4.16% down from last year.
- According to the latest figures from Q3 2025, Silence Therapeutics' Shares Outstanding is $141.7 million, which was down 0.00% from $141.7 million recorded in Q2 2025.
- Silence Therapeutics' Shares Outstanding's 5-year high stood at $184.0 billion during Q3 2024, with a 5-year trough of $121.0 million in Q4 2021.
- For the 3-year period, Silence Therapeutics' Shares Outstanding averaged around $70.8 billion, with its median value being $177.2 million (2024).
- In the last 5 years, Silence Therapeutics' Shares Outstanding crashed by 90.41% in 2022 and then spiked by 3,308.29% in 2023.
- Over the past 5 years, Silence Therapeutics' Shares Outstanding (Quarterly) stood at $121.0 million in 2021, then grew by 4.48% to $126.5 million in 2022, then climbed by 16.65% to $147.5 million in 2023, then declined by 3.95% to $141.7 million in 2024, then decreased by 23.00% to $141.7 million in 2025.
- Its Shares Outstanding was $141.7 million in Q3 2025, compared to $141.7 million in Q2 2025 and $141.7 million in Q1 2025.